AnHorn Medicines Presents Research of Novel Protein Degrader for Topical Use at ISID Meeting 2023

/PRNewswire/ -- AnHorn Medicines, a private biotechnology company focused on developing precision medicines for degrading disease-causing proteins, presented...

Related Keywords

Taiwan ,Taipei ,T Ai Pei ,Tokyo ,Japan ,Chu Chiang Lin ,Linkedin ,Sunplus Technology ,Angel Club ,Industrial Technology Investment Corporation ,First International Societies For Investigative Dermatology Meeting ,Drug Development ,Horn Medicines ,First International Societies ,Investigative Dermatology Meeting ,Concurrent Mini Symposium ,Taian Technologies ,Hong Tai Electric Industrial ,Black Marble Capital Management ,Mega Venture Capital ,Anhorn Medicines ,